Dustin Fontenot
Physician Assistant · Round Rock, TXNPI 1508046715
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (41.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Axonics, Inc. accounts for 74.5% of it on its own, with 35 other manufacturers making up the rest. Reporting peaked in 2024 at $20,603 and has fallen 59.5% since, to $8,352 in 2025. Among physician assistant clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 343 payments — averaging $136.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$35K
- Boston Scientific$7K
- Coloplast$2K
- 180 Medical, Inc.$400
- Endo Pharmaceuticals Inc.$261
- Novo Nordisk$223
- plus $2K from 30 others
What the payments were for
- Consulting fees$19,32341%
- Speaking & faculty fees$3,4847%
- Travel & lodging$14,06230%
- Food & beverage$9,79821%
- Education$1000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 179 | $34,861 |
| Boston Scientific | 29 | $6,943 |
| Coloplast | 12 | $1,960 |
| 180 Medical, Inc. | 10 | $400 |
| Endo Pharmaceuticals Inc. | 18 | $261 |
| Novo Nordisk | 6 | $223 |
| Clarus Therapeutics Inc. | 9 | $191 |
| AbbVie(2 entities) | 7 | $163 |
| Progenics Pharmaceuticals, Inc. | 2 | $157 |
| Antares Pharma, Inc. | 9 | $155 |
| Astellas Pharma US Inc | 3 | $135 |
| Procept Biorobotics Corporation | 5 | $130 |
| Olympus America Inc. | 4 | $111 |
| Ferring Pharmaceuticals Inc. | 6 | $105 |
| Myriad Genetic Laboratories, Inc. | 4 | $103 |
| Endo USA, Inc. | 4 | $88 |
| Tolmar, Inc. | 3 | $85 |
| Teleflex LLC | 5 | $84 |
| Agiliti Surgical, Inc. | 1 | $79 |
| Acerus Pharmaceuticals Corporation | 4 | $57 |
| Urogen Pharma, Inc. | 3 | $57 |
| Halozyme Inc | 3 | $54 |
| Abiomed | 1 | $45 |
| Travere Therapeutics, Inc. | 2 | $41 |
| Myovant Sciences Inc. | 2 | $38 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
| Dendreon Pharmaceuticals LLC | 1 | $35 |
| Hollister Incorporated | 1 | $27 |
| Immunitybio, Inc. | 1 | $26 |
| Laborie Medical Technologies Corp. | 1 | $20 |
| Bayer | 1 | $18 |
| Verity Pharmaceuticals Inc. | 1 | $18 |
| Nevro Corp. | 1 | $17 |
| Millicent US Inc | 1 | $17 |
| Novartis | 1 | $15 |
| Rochester Medical Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Axonics$35,346
- TITAN$1,789
- Bulkamid$245
- Axonics r-SNM System$245
- PYLARIFY$133
- GENERAL BPH$126
- Ozempic$109
How this compares
$46,767 in reported general payments places this provider in the 95th percentile of 8,308 physician assistant providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 32 | $22,015 |
| MyrbetriqMirabegron | 27 | $20,999 |
| XyostedTestosterone Enanthate | 11 | $6,460 |
| Testosterone Cypionate | 60 | $3,119 |
| Tamsulosin Hcl | 97 | $1,055 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 55 | $1,004 |
| Trospium Chloride | 22 | $819 |
| Tadalafil | 14 | $560 |
| Solifenacin Succinate | 25 | $519 |
| Finasteride | 16 | $235 |
| Ciprofloxacin Hcl | 33 | $142 |
| Oxybutynin Chloride ErOxybutynin Chloride | 14 | $101 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 42 | $81 |
| Anastrozole | 15 | $60 |
| Diazepam | 34 | $35 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $36 | $22,01532 claims |
| Astellas Pharma US IncMyrbetriq | $135 | $20,99927 claims |
| Antares Pharma, Inc.Xyosted | $155 | $6,46011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,308 physician assistant providers in Texas.
Other physician assistant in Round Rock
- Cynthia TrickettDallas$1.3M
- Kristine KuceraMelissa$797K
- Selina SantosAustin$543K
- Matthew BrunoMcKinney$538K
- Brooke HodnickSouthlake$479K
- Holly GloverArlington$418K
- Kirk GautierAthens$416K
- Jaime RomanPlano$338K
- Michael WhiteDallas$276K
- Heidi JeffreysLubbock$259K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.